Tempest Therapeutics Inc’s recently made public that its Owner Versant Venture Capital VI, L. acquired Company’s shares for reported $0.43 million on Aug 12 ’24. In the deal valued at $1.10 per share,387,999 shares were bought.
Then, Versant Venture Capital VI, L. sold 400,000 shares, generating $540,040 in total proceeds. Upon selling the shares at $1.35, the 10% Owner now owns 597,940 shares.
Before that, Versant Venture Capital VI, L. sold 387,999 shares. Tempest Therapeutics Inc shares valued at $426,993 were divested by the 10% Owner at a price of $1.10 per share. As a result of the transaction, Versant Venture Capital VI, L. now holds 209,941 shares, worth roughly $0.19 million.
Scotiabank initiated its Tempest Therapeutics Inc [TPST] rating to a Sector outperform in a research note published on March 14, 2024; the price target was $13. A number of analysts have revised their coverage, including Jefferies’s analysts, who began to cover the stock in early February with a ‘”a Buy”‘ rating.
Price Performance Review of TPST
On Tuesday, Tempest Therapeutics Inc [NASDAQ:TPST] saw its stock fall -4.22% to $0.89. Over the last five days, the stock has lost -3.89%. Tempest Therapeutics Inc shares have risen nearly 6.24% since the year began. Nevertheless, the stocks have fallen -77.89% over the past one year. While a 52-week high of $6.00 was reached on 01/06/25, a 52-week low of $0.70 was recorded on 01/02/25. SMA at 50 days reached $0.9008, while 200 days put it at $1.8471.
Levels Of Support And Resistance For TPST Stock
The 24-hour chart illustrates a support level at 0.8627, which if violated will result in even more drops to 0.8389. On the upside, there is a resistance level at 0.9277. A further resistance level may holdings at 0.9689. The Relative Strength Index (RSI) on the 14-day chart is 48.56, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.0085, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 61.99%. Stochastics %K at 47.90% indicates the stock is a holding.
How much short interest is there in Tempest Therapeutics Inc?
A steep rise in short interest was recorded in Tempest Therapeutics Inc stocks on 2024-10-31, growing by 0.78 million shares to a total of 2.64 million shares. Yahoo Finance data shows the prior-month short interest on 2024-09-30 was 1.86 million shares. There was a rise of 29.42%, which implies that there is a positive sentiment for the stock.
